Cyclin-dependent kinase inhibitors (CKIs) and hematological malignancies

Hematology and Cell Therapy

Volumn 38, Issue 4, 1996, Pages 313-323

  Baghdassarian, N ^a   Ffrench, M ^b  

^a Rockefeller Faculty   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

CDKs; cell cycle; CKIs; cyclins; hematological malignancies

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLINE;

CELL CYCLE; GENE MUTATION; HUMAN; LEUKEMIA; REVIEW;

EID: 0029747162     PISSN: 14302772     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00282-996-0313-4     Document Type: Review

References (79)

1. Aprelikova O, Xiong Y, Liu ET (1995) Both p16 and p21 families of cyclin-dependent kinase (CDK) inhibitors block the phosphorylation of cyclin-dependent kinases by CDK-activating kinase. J Biol Chem 270 : 18195-18197
2. Bhatia K, Fan S, Spangler G et al (1995) A mutant p21 cyclin-dependent kinase inhibitor isolated from a Burkin's lymphoma. Cancer Res 55 : 1431-1435
3. Bond fA, Blaydes JP, Rowson J, et al (1995) Mutant p53 rescues human diploid cells from senescence without inhibiting the induction of SDI1/WAF1. Cancer Res 55 : 2404-2409
4. K1P1. Blood 86 : 3869-3875
5. 16ink4. Mol Cell Biol 15 : 2682-2688
6. Chen J, Jackson PK, Kirschner MW et al (1995) Separate domains of p21 involved in the inhibition of cdk kinase and PCNA. Nature 374 : 386-388
7. Demetrick DJ, Matsumoto S, Hannon GJ, et al (1995) Chromosomal mapping of the genes for the human cell cycle proteins cyclin C (CCNC), cyclin E (CCNE), p21 (CDKN1) and KAP (CDKN3). Cytogenet Cell Genet 69 : 190-192
8. El-Deiry WS, Tokino T, Velculescu VE, et al (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75 : 817-825
9. El-Deiry WS, Harper JW, O'Connor PM, et al (1994) WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 54 : 1169-1174
10. Fizzotti M, Cimino G, Pisegna S, et al (1995) Detection of homozygous deletions of the cyclin-dependent kinase 4 inhibitor (p16) gene in acute lymphoblastic leukemia and association with adverse prognostic features. Blood 85 : 2685-2690
11. Flores-Rozas H, Kelman Z, Dean FB, et al (1994) Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase holoenzyme. Proc Natl Acad Sci 91 : 8655-8659
12. INK4B in non-Hodgkin's lymphomas. Blood 86 : 1534-1539
13. C1p1 cyclin dependent kinase inhibitor. Oncogene 10 : 001-007
14. INK4B/MTS2- related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev 8 : 2939-2952
15. Hall M, Bates S, Peters G (1995) Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins. Oncogene 11 : 1581-1588
16. INK4B is a potential effector of TGF-B induced cell cycle arrest. Nature 371 : 257-261
17. CDKN2 expression and its implications for cell immortalization and senescence. Mol Cell Biol 16 : 859-867
18. Harper JW, Adami GR, Wei N et al (1993) The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75 : 805-816
19. KIP2, a cyclin-dependent kinase inhibitor, in mouse. Nat Genet 11 : 204-206
20. Hatta Y, Hirama T, Miller CW, et al (1995) Homozygous deletions of the p15 (MTS2) and p16 (CDKN2/MTS1) genes in adult T-cell leukemia. Blood 85 : 2699-2704
21. IKK4B) display frequent homozygous deletions in primary cells from T- but not from B-cell lineage acute lymphoblastic leukemias. Blood 84 : 4038-4044
22. WAF1/CIP1/SDI1. Oncogene 11 : 1409-1415
23. Hirai H, Roussel MF, Kato J-Y et al (1995) Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. MoL Cell Biol 15 : 2672-2681
24. INK4A and p18, in childhood T cell lineage acute lymphoblastic leukemias. Leukemia 10 : 255-260
25. Jen J, Harper JW, Bigner SH et al (1994) Deletion of p16 and p15 genes in brain tumors. Cancer Res 54 : 6353-6358
26. INK4 gene mediated by an adenovirus vector. Cancer Res 55 : 3250-3253
27. Kamb A, Gruis NA, Weaver-Feldhaus J et al (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science 264 : 436-440
28. Kip1) of cyclin-dependent kinase 4 activation. Cell 79 : 487-496
29. Kawamata N, Morosetti R, Miller CW et al (1995) Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies. Cancer Res 55 : 2266-2269
30. Cip1. Oncogene 11 : 1675-1683
31. KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev 9 : 639-649
32. Li Y, Nichols MA, Shay JW et al (1994) Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb. Cancer Res 54 : 6078-6082
33. Li R, Waga S, Hannon Gj et al (1994) Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature 371 : 534-537
34. Lois AF, Cooper LT, Geng Y et al (1995) Expression of the p16 and p15 cyclin-dependent kinase inhibitors in lymphocyte activation and neuronal differentiation. Cancer Res 55 : 4010-4013
35. Macleod KF, Sherry N, Hannon G et al (1995) p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev 9 : 935-944
36. kIP1 gene to human chromosome 12p12.3. Hum Genet 96 : 558-570
37. CIP1 cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev 9 : 650-662
38. ink4 requires functional retinoblastoma protein. Proc Natl Acad Sci USA 92 : 6289-6593
39. KIP1 gene in Non-Hodgkin's lymphomas and adult T-cell leukemia/lymphoma. Blood 86 : 1924-1930
40. Murphy SB, Raimondi SC, Rivera GK et al (1989) Nonrandom abnormalities of chromosome 9p in childhood acute lymphoblastic leukemia: association with high-risk clinical features. Blood 74 : 409
41. Nakao M, Yokota S, Kaneko H et al (1996) Alterations of CDKN2 gene structure in childhood acute lymphoblastic leukemia: mutations of CDKN2 are observed preferentially in T lineage. Leukemia 10 : 249-254
42. Nobori T, Miura K, Wu DJ et al (1994) Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368 : 753-736
43. Noda A, Ning Y, Venable SF et al (1994) Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 211 : 90-98
44. KiP1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372 : 570-573
45. Ogawa S, Hirano N, Sato N et al (1994) Homozygous loss of the cyclin-dependent kinase 4-inhibitor (p16) gene in human leukemias. Blood 84 : 2431-2435
46. INK4B/MTS2 in human leukemias and lymphomas. Cancer Res 55 : 1436-1440
47. Otsuki T, Jaffe ES, Wellmann A et al (1996) Absence of p18 mutations or deletions in lymphoid malignancies. Leukemia 10 : 356-360
48. Pagano M, Tam SW, Theodoras AM et al (1995) Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269 : 682-685
49. INK4/MTS1 tumour suppressor gene product. EMBO J 14 : 503-511
50. kip1 gene to 12p13 and its analysis in leukemias. Cancer Res 55 : 1206-1210
51. KiP1, a cyclin-Cdk inhibitor, links transforming growth factor- and contact inhibition to cell cycle arrest. Genes Dev 8 : 9-22
52. KiP1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78 : 59-66
53. Kip1: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors. Cancer Res 55 : 1211-1214
54. Quelle DE, Zindy F, Ashmun RA et al (1995) Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83 : 993-1000
55. ink4 gene inactivation in acute lymphocytic leukemia. Blood 85 : 3431-3436
56. Sato Y, Suto Y, Pietenpol J et al (1995) TEL and KIP1 define the smallest region of deletions on 12p13 in hematopoietic malignancies. Blood 86 : 1525-1533
57. Kip1 gene in childhood acute lymphoblastic leukemia (ALL) Leukemia 10 : 345
58. Serrano M, Hannon GJ, Beach D (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366 : 704-707
59. INK4. Science 267 : 249-252
60. Sherr CJ (1993) Mammalian G, cyclins. Cell 73 : 1059-1065
61. Shiohara M, El-Deiry WS, Wada M et al (1994) Absence of WAF1 mutations in a variety of human malignancies. Blood 84 : 3781-3784
62. Sill H, Goldman JM, Cross NCP (1995) Homozygous deletions of the p16 tumor-suppressor gene are associated with lymphoid transformation of chronic myeloid leukemia. Blood 85 : 2013-2016
63. Slingerland JM, Hengst L, Pan CH et al (1994) A novel inhibitor of cyclin-cdk activity detected in transforming growth factor-β-arrested epithelial cells. Mol Cell Biol 14 : 3683-3694
64. Soucek T, Pusch O, Hengstschlager-Ottnad E et al (1995) Expression of the cyclin-dependent kinase inhibitor p16 during the ongoing cell cycle. FEBS Lett 373 : 164-169
65. Stegmaier K, Takeuchi S, Golub TR et al (1996) Mutational analysis of the candidate tumor suppressor genes TEL and KIP1 in childhood acute lymphoblastic leukemia. Cancer Res 56 : 1413-1417
66. Steinman RA, Hoffman B, Iro A et al (1994) Induction of p21 (WAF1/CIP1) during differentiation. Oncogene 9 : 3389-3396
67. Stone S, Dayananth P, Jiang P et al (1995) Genomic structure, expression and mutational analysis of the p15 (MTS2) gene. Oncogene 11 : 987-991
68. Stranks G, Height SE, Mitchell P et al (1995) Deletions and rearrangement of CDKN2 in lymphoid malignancy. Blood 85 : 893-901
69. Takeuchi S, Bartram CR, Seriu T et al (1995) Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood. Blood 86 : 755-760
70. Ink. Cancer Res 54 : 5816-5820
71. Toyoshima H, Hunter T (1994) p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to p21. Cell 78 : 67-74
72. ink4A) gene in primary B-cell lymphoma. Blood 86 : 2724-2731
73. Waga S, Hannon GJ, Beach D et al (1994) The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369 : 574-578
74. Watanabe H, Fukuchi K, Takagi Y et al (1995) Molecular analysis of the Cip1/Waf1 (p21) gene in diverse types of human tumors. Biochem Biophys Acta 1263 : 275-280
75. Xiong Y, Hannon GJ, Zhang H et al (1993) p21 is a universal inhibitor of cyclin kinases. Nature 366 : 701-704
76. Xiong Y, Zhang H, Beach D (1993) Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes Dev 7 : 1572-1583
77. Ink4a tumor suppressor protein. Cancer Res 55 : 2503-2506
78. Waf is contained in its N-terminal half ('half-WF'). Oncogene 11 : 393-395
79. Zhang H, Hannon GJ, Beach D (1994) p21-containing cyclin kinases exist in both active and inactive states. Genes Dev 8 : 1750-1758